Lurch & Ferris Buehler

[cj001f]

check your source there cj10101010f - patent rights for pharmaceuticals werre reduced specifically to encourage quick generic copying thus lowering prices.

WTF is yours Dru?

"While the role and authority of the PMPRB are still being examined, the recommendation to maintain the 20-year term for patent protection was accepted. On March 12, 1998 the federal government of Canada implemented changes to the Patented Medicines Regulations (Linkage Regulations) to ensure that pharmaceutical patents are respected without delaying market entry of generic drugs."

http://www.merckfrosst.ca/e/health/patent/home.html

The original term of 7 years after marketing would be longer than most US drugs receive

[Dru]

Like I just posted above, the patent lasts 20 years but the patent exclusion act allows the generic to manufacture before the patent expires.

[Dru]

oh what the hell,

 

we had it, we don't have it, we have it again

 

doesnt anyone update their damn web page anymore?

 

here's what lorne has to say

[assmonkey]

This sticker sucks. They should spend some money and hire a designer. Dumbasses.

 

[MervGriffin]

[JayB]

The neat thing about most other countries is that they "encourage" pharmaceutical companies to sell their drugs at fixed price by informing them that if they refuse to do so, they will be unable to enforce the patent protection on the said drug. Nice.

 

Brazil, which recently blackmailed the pharmaceutical companies into such a pricing scheme for anti-HIV drugs, had a health minister crowing about how he saved the Brazilian taxpayer a couple hundred million dollars in such a manner.

 

What he did not say was that Brazil was simultaneously engaged in an effort to cultivate the biotechnology/pharmeceutical sector into a major contributor to Brazil's GDP. By demonstrating that Brazil will refuse to acknowledge intellectual property rights whenever it sees fit, the said minister just killed off whatever chance Brazil had to compete in this sector, and any other sector that requires such protections (like software) and in so doing cost his countrymen several times more than a couple hundred million dollars in direct investment in the biotech/pharmaceutical sector alone, not to mention any future tax yields that the additional investment in those sectors might have generated in the future. Classic.